Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity
Cell Reports · 2025-09 · 44 (9) · 116223
DOI: 10.1016/j.celrep.2025.116223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-09. Verfasst von Rômulo Silva de Oliveira und 15 weiteren Autor:innen. Beteiligte Einrichtung: M3 Research Center, Faculty of Medicine, University of Tübingen, Tübingen, Germany; Department of Internal Medicine I, Faculty of Medicine, Universit…. Hauptthemen laut MEDLINE: Bifidobacterium, Polysaccharides, Bacterial, Colonic Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, Canadian Institutes of Health Research, German Cancer Aid.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- M3 Research Center, Faculty of Medicine, University of Tübingen, Tübingen, Germany; Department of Internal Medicine I, Faculty of Medicine, University of Tübingen, Tübingen, Germany; Cluster of Excellence EXC 2124 Contr…
- Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- M3 Research Center, Faculty of Medicine, University of Tübingen, Tübingen, Germany; Department of Internal Medicine I, Faculty of Medicine, University of Tübingen, Tübingen, Germany.
- Institute of Immunology, Department of Innate Immunity, University of Tübingen, Tübingen, Germany.
- International Microbiome Centre, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- M3 Research Center, Faculty of Medicine, University of Tübingen, Tübingen, Germany.
Förderung
- Horizon 2020
- Canadian Institutes of Health Research
- German Cancer Aid
- Austrian Science Fund
- European Research Council
- DFG
Zitieren
APA
Silva de Oliveira, R., Shupe, A., Krause, T., Richardo, T., Ohland, C., Sabachvili, M., Bucher, K., Hetzer, J., Hörner, S., Dauch, D., Heikenwälder, M., Trautwein, C., Weber, A. N. R., Klepsch, V., McCoy, K. D., & Mager, L. F. (2025). Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity. Cell Reports, 44(9), 116223. https://doi.org/10.1016/j.celrep.2025.116223
Vancouver
Silva de Oliveira R, Shupe A, Krause T, Richardo T, Ohland C, Sabachvili M, et al. Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity. Cell Reports. 2025;44(9):116223. doi:10.1016/j.celrep.2025.116223
BibTeX
@article{SilvadeOliveira2025,
author = {Silva de Oliveira, Rômulo and Shupe, Amy and Krause, Tim and Richardo, Timmy and Ohland, Christina and Sabachvili, Mahana and Bucher, Kirsten and Hetzer, Jenny and Hörner, Sebastian and Dauch, Daniel and Heikenwälder, Mathias and Trautwein, Christoph and Weber, Alexander N R and Klepsch, Victoria and McCoy, Kathy D and Mager, Lukas F},
title = {Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {9},
pages = {116223},
doi = {10.1016/j.celrep.2025.116223}
}
EUVIMED